DENVER, Sept. 17 /PRNewswire-FirstCall/ -- Global Med Technologies((R)), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, today announced that Michael I. Ruxin, M.D., Global Med's Chairman and CEO, will make a major new product announcement the morning of the LDV Growth & Value Equity Conference which will be held at The Embassy Suites Boca Raton Hotel, Boca Raton, Florida. Dr. Ruxin will also demo the breakthrough product at the conference. To RSVP and arrange one-on-one private sessions, please call James DePelisi at (954) 746-3117 or email: Ldvtrade@aol.com.
The breakthrough medical product announcement will be concerning an innovative, European RFID medical device, that has just come on the market, and that has little competition with older medical device technologies that currently exist in the same area. Market penetration of these older medical devices is less than 10% in the U.S. market and has minimal penetration in international markets. The main reasons for the small market penetration globally are the high cost of these older medical devices, lengthy staff education needed to implement, and overall difficulty of use. Global Med's new RFID product will overcome all three of these concerns. The product is currently not for sale in the U.S., but is being sold in Europe. Global Med intends to apply for FDA clearance of the product in the near future.
About Global Med Technologies((R)), Inc.
Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.
Global Med's domestic companies are Wyndgate Technologies((R)), a leader in software products and services for donor centers and hospital transfusion services; eDonor((R)), which offers web-based donor relationship management systems; and PeopleMed((TM)), Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer of *donor center and *transfusion management systems as well as cellular therapy software, *laboratory information systems and quality assurance medical software systems internationally.
*Products are not marketed in the United States.
For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
|SOURCE Global Med Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved